Skip to main content

Evidence review

Peptide Detail

Library/NMN (Nicotinamide Mononucleotide)
emergingCautionSupplement

NMN (Nicotinamide Mononucleotide)

Nicotinamide Mononucleotide / Beta-NMN

A nucleotide derived from ribose and nicotinamide that serves as a direct precursor to NAD+ (nicotinamide adenine dinucleotide). NAD+ is an essential coenzyme in >500 enzymatic reactions including sirtuins (SIRT1-7), PARPs, and CD38. NAD+ levels decline ~50% between ages 40–60, correlating with mitochondrial dysfunction and aging. NMN supplementation restores NAD+ levels in human studies, though long-term clinical benefits are still being established.

Half-life

~2–3 hours (oral NMN; NAD+ elevation lasts longer)

Typical Dose

250–1000 mg/day

600/1000

Route

oral

Category

metabolic

Evidence Overview

Strength of evidence across clinical, expert, and experimental lanes.

How NMN (Nicotinamide Mononucleotide) is dosed in practice

Usually taken by mouth. Typical range: 250–1000 mg/day. Half-life: ~2–3 hours (oral NMN; NAD+ elevation lasts longer). Each card gives the dose, frequency and duration from one evidence lane: Clinical (human trials), Expert (practitioner protocols) or Experimental (early or animal data). These ranges describe what has been studied or used; they are not a prescription.

Work out the units to draw with the reconstitution calculator, how long a vial lasts with the vial duration calculator, and how levels fall between doses with the half-life calculator.

clinical65% confidence

Randomized trials giving 250–900 mg daily for 6–12 weeks raised blood NAD+. A 10-week trial in overweight postmenopausal women with prediabetes (2021) found better muscle insulin sensitivity; effects on physical performance elsewhere were small.

Dose250–900 mg daily
FrequencyOnce daily, typically morning
Duration6–12 weeks in randomized trials
Sources
  • Randomized trial in postmenopausal women with prediabetes (2021)
  • Dose-ranging randomized trial (2023)
expert60% confidence

Popularized as a longevity supplement. Typically dosed 500–1000 mg daily, sublingual or oral, often combined with resveratrol and TMG (trimethylglycine). Taken in the morning. Look for enzymatically produced NMN for purity.

Dose500–1000 mg daily
FrequencyOnce daily in the morning
DurationOngoing daily supplementation
Sources
  • Longevity medicine NAD+ restoration strategies
  • NMN quality and bioavailability research
experimental55% confidence

Massively popular in the longevity supplement market. Users report improved energy, better exercise recovery, and enhanced mental clarity — though placebo effects are hard to rule out. Sublingual formulations claim better bioavailability. Price has dropped significantly as manufacturing scaled. FDA attempted to ban NMN as a supplement (2022) but enforcement is ongoing.

Dose250–1000 mg daily
FrequencyOnce daily, morning
DurationOngoing
Sources
  • r/NMN community experience reports
  • Longevity supplement comparison reviews
  • FDA NMN regulatory status updates

Unlock Full Evidence Sources

Get complete clinical data, expert protocols, and experimental research for NMN (Nicotinamide Mononucleotide) and 90+ other compounds with Pro.

Upgrade to Pro

Safety & Contraindications

  • Active cancer (NAD+ fuels rapidly dividing cells — theoretical concern)
  • Gout (purine metabolism pathway involvement)
  • Pregnancy or breastfeeding (insufficient safety data)

NMN (Nicotinamide Mononucleotide): common questions

What is NMN (Nicotinamide Mononucleotide)?

A nucleotide derived from ribose and nicotinamide that serves as a direct precursor to NAD+ (nicotinamide adenine dinucleotide). NAD+ is an essential coenzyme in >500 enzymatic reactions including sirtuins (SIRT1-7), PARPs, and CD38. NAD+ levels decline ~50% between ages 40–60, correlating with mitochondrial dysfunction and aging. NMN supplementation restores NAD+ levels in human studies, though long-term clinical benefits are still being established.

How is NMN (Nicotinamide Mononucleotide) dosed?

NMN (Nicotinamide Mononucleotide) is usually taken by mouth. Typical range in DoseCraft's library: 250–1000 mg/day. Clinical (human trials): 250–900 mg daily; Once daily, typically morning; 6–12 weeks in randomized trials. Expert (practitioner protocols): 500–1000 mg daily; Once daily in the morning; Ongoing daily supplementation. Experimental (early or animal data): 250–1000 mg daily; Once daily, morning; Ongoing. These ranges describe what has been studied or used; they are not a prescription.

Is NMN (Nicotinamide Mononucleotide) FDA-approved?

NMN (Nicotinamide Mononucleotide) is sold as a dietary supplement, which the FDA does not approve for safety or effectiveness before sale.

What is the half-life of NMN (Nicotinamide Mononucleotide)?

DoseCraft's library lists a half-life of ~2–3 hours (oral NMN; NAD+ elevation lasts longer). Half-life sets how often a compound is dosed and how long it takes to clear: about five half-lives.

Who should not use NMN (Nicotinamide Mononucleotide)?

Listed contraindications: Active cancer (NAD+ fuels rapidly dividing cells — theoretical concern); Gout (purine metabolism pathway involvement); Pregnancy or breastfeeding (insufficient safety data).

Information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide regimen.

Page updated . How we grade evidence: methodology.

Disclaimer: DoseCraft is for educational purposes only and does not provide medical advice. These compounds are not FDA-approved for the uses described. Always consult a qualified healthcare provider. Full disclaimer

Pro unlocks unlimited Coach + safety alerts.

Upgrade→